Aquestive Therapeutics, Inc.
$5.5K 214 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Granata Bio Corporation
Granata Bio Corporation reported $5,493.03 across General Payments, Research, and Ownership to 22 physicians and teaching hospitals across 22 transactions.
- $5.5K Below-median payer
- All-tracks total
- 22 Below-median volume
- Transactions
- 22 Below-median reach
- Recipients
- #1703
- of 1,925 companies
Granata Bio Corporation reported $5,493.03 across all CMS Open Payments tracks (General + Research + Ownership) to 22 physicians and teaching hospitals in Program Year 2024 - ranking #1703 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,493.03, averaging $249.68 per recipient.
Granata Bio Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer granata-bio-corporation Granata Bio Corporation
$5.5K · #1703/1,925 · 0.0% industry · PY2024
- TOT $5.5K
- RANK #1703
- SHARE 0.0%
- TXN 22
- RCP 22
- CAT 3
- GEN $5.5K
- TOP1 54.6%
- PY 2024
Volume peers
Nearest volume peer: Aquestive Therapeutics, Inc. ($5.5K)
Granata Bio Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Granata Bio Corporation
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Granata Bio Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Consulting Fee" leads the 3-category general-payment breakdown below at $3.0K (54.6% of General Payments, 1 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Granata Bio Corporation's 3-category general-payment breakdown at $3.0K, 54.6% of the reported total.
How Granata Bio Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $3.0K | 1 | 54.6% |
| Food and Beverage | $1.4K | 19 | 25.1% |
| Travel and Lodging | $1.1K | 2 | 20.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $4,522.19 (82.3%) of $5,493.03 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Granata Bio Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Pietro Bortoletto
$3,000.00 across 1 reported transactions
- 2
Karina Stroker
$1,111.93 across 2 reported transactions
- 3
Peter Lindner
$153.64 across 2 reported transactions
- 4
Ariel Dunn
$153.64 across 2 reported transactions
- 5
Alexandra Poch
$102.98 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Granata Bio Corporation ranks #1703 of 1,925 by total payments (bottom 12% by spend) but is notably more concentrated than that alone would suggest -- #514 of 1,838 by HHI (top 28% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Agile Therapeutics, Inc. : $131.2K total payments, HHI 3462
- Novabone Products : $19.0K total payments, HHI 3461
- NovoSource, LLC : $22.9K total payments, HHI 3460
- Datascope Corp. : $1.6M total payments, HHI 3460
- Bristol Myers Squibb Company : $1.0M total payments, HHI 3447
- Collegium Pharmaceutical, Inc. : $1.5M total payments, HHI 3442
- Granata Bio Corporation (this company) : $5.5K total payments, HHI 3437
- American Rheumatology Network, LLC : $2.8M total payments, HHI 3431
- Biocircuit Technologies Inc : $69.8K total payments, HHI 3424
- Organ Recovery Systems, Inc. : $356.7K total payments, HHI 3422
- Omniscient Neurotechnology America Ltd : $73.2K total payments, HHI 3397
- FlexDex Inc. : $350.51 total payments, HHI 3376
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Granata Bio Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Granata Bio Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Granata Bio Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Karl Storz Endovision, Inc.
$5.5K 3 recipients
Compare payment profiles
Rare Disease Therapeutics, Inc.
$5.6K 104 recipients
Compare payment profiles
Bridge to Life Ltd
$5.6K 9 recipients
Compare payment profiles
ASD Specialty Healthcare, LLC
$5.3K 60 recipients
Compare payment profiles
Canon Healthcare USA, Inc.
$5.3K 15 recipients
Compare payment profiles
Put this to use
Granata Bio Corporation ranks #1703 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Granata Bio Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.